Smithsante Pharmaceuticals Private Limited

Smithsante Pharmaceuticals Private Limited - home appliances in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
CIN U52399TN2015PTC102910 Incorporated 05 November 2015 ROC Chennai HQ Chennai, Tamil Nadu, India
Active Private Limited Company home appliances
Revenue · FY 2024
₹34.25 Lakh
▲ 34% YoY
Net profit · FY 2024
₹2.17 Lakh
Net margin 6.3%
EBITDA · FY 2024
₹2.37 Lakh
EBITDA margin 6.9%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Open charges
₹11 Lakh
Satisfied ₹5 Lakh
Company age
11 yrs
Est. 2015
Directors on board
3
As per MCA filings

About Smithsante Pharmaceuticals Private Limited

Data last updated:

Smithsante Pharmaceuticals Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the specialised retail segment of the home appliances and consumer durables sector. It was incorporated on 05 November 2015 and has been in existence for over 11 years.

The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U52399TN2015PTC102910. Its GSTIN is 33AAWCS3794E1ZU (Tamil Nadu).

The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Venganna Sreenish Kambil (Managing Director) and Mathivanan Venugopal (Whole-Time Director).

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at New No.10A Old No 10A Left Portion Ground Floor Gill Nagar 1st Street Gill Nagar, Chennai, Tamil Nadu, India – 600094.

As per the financials filed for FY 2024, the company reported a revenue of ₹34.25 Lakh, a growth of 34% compared to the previous year. For the same year it recorded a net profit of ₹2.17 Lakh (net margin 6.3%) and EBITDA of ₹2.37 Lakh (EBITDA margin 6.9%). Revenue has grown at a compounded annual rate (CAGR) of 83% over three years and 5% over five years.

As per MCA filings, the company has open charges of ₹11 Lakh and satisfied charges of ₹5 Lakh on record.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U52399TN2015PTC102910
Registration Number 102910
Incorporation Date 05 November 2015
ROC Chennai
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

Contact details

Smithsante Pharmaceuticals Private Limited's registered office is in Chennai, Tamil Nadu. Its e-mail address is in the company report.

  • Email
  • Registered Address
    New No.10A Old No 10A Left Portion Ground Floor Gill Nagar 1st Street Gill Nagar, Chennai, Tamil Nadu, India – 600094
  • Industry
    Home Appliances, Specialized Stores, Retailers

To see the full contact details of Smithsante Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Smithsante Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Smithsante Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Smithsante Pharmaceuticals Private Limited, buy the company report.

Financials of Smithsante Pharmaceuticals Private Limited

FY 2025 filings available

Smithsante Pharmaceuticals Private Limited reported revenue of ₹34.25 Lakh (up 34% YoY) for FY 2024.

Revenue · FY 2024
₹34.25 Lakh ▲ 34%
Net profit · FY 2024
₹2.17 Lakh margin 6.3%
EBITDA · FY 2024
₹2.37 Lakh margin 6.9%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 34%
3 years · compounded
▲ 83%
5 years · compounded
▲ 5%
EBITDA CAGR growth
1 year
▲ 81%
3 years · compounded
▲ 47%
5 years · compounded
▲ 19%

Revenue has grown at a compounded annual rate (CAGR) of 5% over five years, including 34% growth in the latest year. EBITDA rose 81% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹2.37 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹2.17 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin6.9%
Net Profit Margin6.3%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Smithsante Pharmaceuticals Private Limited, buy the company report.

Board of directors of Smithsante Pharmaceuticals Private Limited

Smithsante Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Mathivanan VenugopalWhole-Time Director08 Dec 20232 Years 11 MonthsCurrent
Padinchakara Nirmal KumarWhole-Time Director08 Dec 20232 Years 11 MonthsCurrent
Venganna Sreenish KambilManaging Director05 Nov 201511 Years 0 MonthsCurrent

Peer comparison

Smithsante Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Edmond Pharmaceuticals Private Limited₹34.55 Lakh (FY 2024)100.0%Hyderabad, Telangana, India
Smega Pharmaceuticals Private Limited₹34.32 Lakh (FY 2019)-41.0%Belapur, Maharashtra, India
Smithsante Pharmaceuticals Private Limitedthis company₹34.25 Lakh (FY 2024)₹2.17 Lakh6.3%34.0%Chennai, Tamil Nadu, India
Sunbiosmith Pharmaceuticals Private Limited₹34.24 Lakh (FY 2025)6.0%Dehradun, Uttarakhand, India
Goodness Pharmaceuticals Private Limited₹34.21 Lakh (FY 2022)6.0%Aligarh, Uttar Pradesh, India
Craicean Pharmaceuticals Private Limited₹34.19 Lakh (FY 2024)8.0%Lucknow, Uttar Pradesh, India

To see the full peer comparison of Smithsante Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹11 Lakh
Satisfied charges
₹5 Lakh
Breakdown by lending institutions
Others₹0.11 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
10 Mar 2025101085136Others₹11 LakhOpen
06 Mar 2024100893741Others₹5 LakhSatisfied

To see the full charge records of Smithsante Pharmaceuticals Private Limited, buy the company report.

Total charge records: 2 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Smithsante Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Smithsante Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
33AAWCS3794E1ZUTamil NaduActive01 Jul 2017

To see the full GST registrations and return filing status of Smithsante Pharmaceuticals Private Limited, buy the company report.

Recent activity

Smithsante Pharmaceuticals Private Limited has 6 board changes on record since 2015: 4 appointments and 2 cessations. The latest: Rajiv Tandon ceased to be Whole-Time Director on 23 Feb 2025.

AGM
Smithsante Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Smithsante Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Charges
A charge registered on 06 Mar 2024 via Charge ID 100893741 with Others was fully satisfied on 15 Mar 2025.
Charges
A charge with Others amounted to Rs. 11.00 Lakh with Charge ID 101085136 was registered on 10 Mar 2025.
Ceased
Rajiv Tandon ceased to be Whole-Time Director.
Charges
A charge with Others amounted to Rs. 5.00 Lakh with Charge ID 100893741 was registered on 06 Mar 2024.
Appointed
Mathivanan Venugopal was appointed as Whole-Time Director.
Appointed
Padinchakara Nirmal Kumar was appointed as Whole-Time Director.
Ceased
Govindarajan Kumar ceased to be Director.
Appointed
Rajiv Tandon was appointed as Whole-Time Director.
Appointed
Venganna Sreenish Kambil was appointed as Managing Director.
Incorporation
05 Nov 2015
Smithsante Pharmaceuticals Private Limited was registered on 05 Nov 2015 with Roc Chennai & aged 11 years 12 days as per MCA records.

Frequently asked questions

Smithsante Pharmaceuticals is an active private limited company based in Chennai, Tamil Nadu, India. The company works in specialized stores, within the home appliances industry. It was incorporated on 05 November 2015 (11+ years old) and is registered under CIN U52399TN2015PTC102910.

Smithsante Pharmaceuticals has 3 current directors:

The latest financial statements of Smithsante Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.

The GSTIN of Smithsante Pharmaceuticals is 33AAWCS3794E1ZU, registered in Tamil Nadu.

The CIN (Corporate Identification Number) of Smithsante Pharmaceuticals is U52399TN2015PTC102910. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Smithsante Pharmaceuticals was incorporated on 05 November 2015, making it 11+ years old. It is registered with the Registrar of Companies, Chennai.

The peers of Smithsante Pharmaceuticals by revenue are Edmond Pharmaceuticals Private Limited, Smega Pharmaceuticals Private Limited, Sunbiosmith Pharmaceuticals Private Limited, Goodness Pharmaceuticals Private Limited, Craicean Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).

Rajiv Tandon ceased to be Whole-Time Director on 23 Feb 2025. Mathivanan Venugopal was appointed as Whole-Time Director on 08 Dec 2023. Padinchakara Nirmal Kumar was appointed as Whole-Time Director on 08 Dec 2023. Smithsante Pharmaceuticals has 6 board changes on record in total.

The registered office of Smithsante Pharmaceuticals is at New No.10A Old No 10A Left Portion Ground Floor Gill Nagar 1st Street Gill Nagar, Chennai, Tamil Nadu, India – 600094.

Smithsante Pharmaceuticals operates in the home appliances industry, in the specialized stores segment.

Smithsante Pharmaceuticals has open charges of ₹11 Lakh and satisfied charges of ₹5 Lakh as per latest MCA filings.